Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to β-amyloid peptide

Journal of Neuroscience Research

Volumn 55, Issue 1, 1999, Pages 44-53

  Deb, Suman ^a   Zhang, J Wenjun ^a   Gottschall, Paul E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Extracellular matrix; Gelatinases; Protease

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; FURIN; GELATINASE A; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ALZHEIMER DISEASE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EXTRACELLULAR MATRIX; GLIOMA CELL; HUMAN; HUMAN CELL; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN POLYMORPHISM;

AMYLOID BETA-PROTEIN; BRAIN NEOPLASMS; ENZYME INDUCTION; ENZYME INHIBITORS; FURIN; GELATINASES; GLIOBLASTOMA; HUMANS; IMMUNOBLOTTING; ISOENZYMES; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; PEPTIDE FRAGMENTS; PRECIPITIN TESTS; SUBTILISINS; TUMOR CELLS, CULTURED;

EID: 0032900361     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990101)55:1<44::AID-JNR6>3.0.CO;2-G     Document Type: Article

References (60)

1. Alexander CM, Howard EW, Bissell MJ, Werb Z. 1987. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 135:1669-1677.
2. Angliker H, Wilstrom P, Shaw E, Brenner C, Fuller RS. 1993. The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast. Biochem J 293:75-81.
3. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ. 1990. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329.
4. Araujo DM, Cotman CW. 1992. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 569:141-145.
5. Backstrom JR, Miller CA, Tokes ZA. 1992. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: Identification of calcium-dependent metalloproteinases from the hippocampus. J Neurochem 58:983-992.
6. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA. 1996. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide. J Neurosci 16:7910-7919.
7. Bignami A, LeBlanc A, Pendes G. 1994. A role for extracellular matrix degradation and matrix metalloproteinases in senile dementia? Acta Neuropathol 87:308-312.
8. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
9. Canning DR, Mckeon RJ, DeWitt DA, Perry G, Wujek JR, Frederickson RCA, Silver J. 1993. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 124:289-298.
10. Chen Z, Strickland S. 1997. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91:917-925.
11. Cotman CW, Pike CJ, Copani A. 1992. β-amyloid neurotoxicity: A discussion of in vitro findings. Neurobiol Aging 13:587-590.
12. Crawford HC, Matrisian LM. 1994. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14:234-245.
13. Deb S, Gottschall PE. 1996. Increased production of matrix metalloproteinases in astrocytes and mixed hippocampal cultures treated with β-amyloid peptide. J Neurochem 66:1641-1647.
14. D'ortho M, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751-757.
15. Emmert-Buck M, Emonard HP, Corcoran ML, Krutzsch HC, Foidart JM, Stetler-Stevenson WG. 1995. Cell surface binding of TIMP-2 and proMMP-2/TIMP-2 complex. FEBS Lett 364:28-32.
16. Emsberger U, Edgar D, Rohrer H. 1989. The survival of early chick sympathetic neurons in vitro is dependent on a suitable substrate but independent of NGF. Dev Biol 135:250-262.
17. Goldberg GI, Marmer BL, Grant JA, Eisen AZ, Wilhelm S and He C. 1989. Human 72 K type collagenase forms a complex with a tissue inhibitor of metalloproteinase designed TIMP-2. Proc Natl Acad Sci USA 86:8207-8211.
18. Gottschall PE, Deb S. 1996. Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmuno-modulation 3:69-75.
19. Gottschall PE, Yu X. 1995. Cylokines regulate gelatinase A and B (matrix metalloproteinase: MMP-2 and MMP-9) activity in cultured rat astrocytes. J Neurochem 64:1513-1520.
20. Gottschall PE, Koves K, Mizuno K, Tatsuno I, Arimura A. 1991. Glucocorticoid up-regulation of interleukin-1 (IL-1) receptor expression in a glioblastoma cell line. Am J Physiol 261:E362-E368.
21. Gottschall PE, Yu X, Bing B. 1995. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated microglia in culture. J Neurosci Res 42:335-342.
22. Hoke A, Canning DR, Malemud CJ, Silver J. 1994. Regional differences in reactive gliosis induced by substrate bound β-amyloid. Exp Neurol 130:56-66.
23. Hooper NM, Karran HK, Turner AJ. 1997. Membrane protein secretases. Biochem J 321:265-279.
24. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S. 1997. Unaltered secretion of β-amyloid precursor protein in Gelatinase A (Matrix metalloproteinase 2)-deficient mice. J Biol Chem 272: 22389-22392.
25. Kalcheim C, Barde YA, Thoenen H, Douarin NM. 1987. In vivo effect of brain-derived neurotrophic factor on the survival of developing dorsal root ganglion cells. EMBO J 6:2871-2873.
26. Kleiner DE, Stetler-Stevenson WG. 1994. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 218:325-329.
27. LePage R, Fosang J, Fuller SJ, Murphy G, Evin G, Beyreuther K, Masters CL, Small DH. 1996. Gelatinase A possesses a β-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease. FEBS Lett 377:267-270.
28. Letourneau PC, Condic ML, Snow DM. 1994. Interactions of developing neurons with the extracellular matrix. J Neurosci 14:915-928.
29. Lohi J, Lehti K, Westermarck J, Kahari V, Keski-Oja J. 1996. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristale 13-acetate. Eur J Biochem 239:239-247.
30. Matrisian LM. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125.
31. Mattson MP, Murrain M, Guthrie PB, Kater SB. 1989. Fibroblast growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal architecture. J Neurosci 9:3728-3740.
32. Maquoi E, Noel A, Frankenne F, Angliker H, Murphy G, Foidart JM. 1998. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett 424:262-266.
33. Miyazaki K, Hasegawa M, Funahashi K, Umeda M. 1993. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362: 839-841.
34. Miyazaki K, Funahashi K, Umeda M, Nakano A. 1994. Gelatinase A and APP. Nature 368:695-696.
35. Murphy G, Reynolds JJ, Hembry RM. 1989. Metalloproteinases and cancer invasion and metastasis. Int J Cancer 44:757-760.
36. Murtomaki S, Trenkner E, Wright J, Saksela O, Liesi P. 1995. Increased proteolytic activity of the granule neurons may contribute to neuronal death in the weaver mouse cerebellum. Dev Biol 168:635-648.
37. Nelson RB, Siman R. 1989. Identification and characterization of calcium-dependent metalloproteases in rat brain. J Neurochem 53:641-647.
38. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. 1997. Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biochem 272: 2446-2151.
39. Oropeza RL, Wekerle H, Werb Z. 1987. Expression of apolipoprotein E by mouse brain astrocytes and its modulation by interferon-gamma. Brain Res 410:45-51.
40. Pasternack JM, Abraham CR, Van Dyke BJ, Potter H, Younkin SG. 1989. Astrocytes in Alzheimer's disease grey matter express αl-antichymotrypsin mRNA. Am J Pathol 135:827-834.
41. Peress N, Perillo E, Zucker S. 1995. Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain. J Neuropathol Exp Neurol 54:16-22.
42. Pike CJ, Cummings BJ, Cotman CW. 1995. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 132:172-179.
43. Pike CJ, Ramezan-Arab N, Miller S, Cotman C. 1996. β-amyloid increases enzyme activity and protein levels of glutamine synthetase in cultured astrocytes. Exp Neurol. 139:167-171.
44. Rao JS, Steck PA, Mohanam S, Stetler Stevenson WG, Liotta LA, Sawaya R. 1993. Elevated levels of Mr 92000 type IV collagenase in human brain tumors. Cancer Res 53:2208-2211.
45. Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, Fridman R. 1994. Proteolysis of A beta peptide from Alzheimer's disease brain by gelatinase A. Biochem Biophys Res Commun 205: 1755-1761.
46. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
47. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. 1996. Activation of recombinant membrane type-1 matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101-104.
48. Seidah NG, Chretien M, Day R. 1994. The family of subtilisin/kexin like pro-protein and prohormone convertases: Divergent or shared functions. Biochimie 76: 197-209.
49. Strongin AY, Marmer BL, Grant GA, Goldberg GI. 1993. Plasma membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem. 268:14033-14039.
50. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. 1995. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 270:5331-5338.
51. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Marguiles IMK, Liotta LA. 1989. The activation of human type IV collagenase proenzyme. J Biol Chem 264:1353-1356.
52. Takino T, Sato H, Shinagawa A, Seiki M. 1995. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 270:23013-23020.
53. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y. 1997. Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57:2055-2060.
54. Vassalli JD, Pepper MS. 1994. Membrane proteases in focus. Nature 370:14-15.
55. Walsh DM, Williams HC, Kennedy HE, Allsop D, Murphy G. 1994. Gelatinase A not alpha-secretase? Nature 367:27-28.
56. Werb Z, Hembry RM, Murphy G, Aggeler J. 1986. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: Relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol 102:697-702.
57. Woessner JFJ. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
58. Yamada T, Yoshiyama Y, Sato H, Seiki M, Shinagawa A, Takahashi M, 1995a. White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues. Acta Neuropathol 90:421-424.
59. Yamada T, Miyazaki K, Koshikawa N, Takahashi M, Akatsu H, Yamamoto T. 1995b. Selective localization of gelatinase A, an enzyme degrading β-amyloid protein, in white matter microglia and in Schwann cells. Acta Neuropathol 89:199-203.
60. Zhang JW, Deb S, Gottschall PE. 1998. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci (in press).